Stephanie Urschel

Stephanie Urschel, PhD, has extensive work experience in the pharmaceutical industry. Stephanie currently serves as the Vice President of Business Development ICB Europe at Nuvisan, where they are responsible for developing and maintaining relationships with customers in the biotech and pharmaceutical industries. Prior to this role, they held the position of Senior Director of Business Development Non-Clinical Services at Nuvisan, where they managed the DMPK proposal team and played a key role in developing business strategies.

Before joining Nuvisan, Dr. Urschel was the Head of Business Development and Sales for Non-Clinical Studies and Bioanalysis at GBA Group Pharma. Stephanie led the business development team and worked closely with large pharmaceutical companies to provide preclinical research services.

Dr. Urschel also has experience at Pharmacelsus GmbH, where they served as the Head of Sales and Marketing. In this role, they worked closely with the CEO to define and implement marketing and sales strategies for the company's preclinical research services and bioanalytics.

Earlier in their career, Dr. Urschel worked at Thermo Fisher Scientific, where they held various roles including Senior Field Scientist and Field Application Scientist. In these positions, they supported customers in academia and the pharmaceutical industry by providing technical support and training.

Dr. Urschel began their career as a Scientific Staff Member at the Institute for Molecular Genetics at the University of Bonn, where they conducted research projects and taught practical courses and lectures.

Overall, Stephanie Urschel, PhD, has a strong background in business development, sales, and technical support in the pharmaceutical industry.

Stephanie Urschel PhD earned their PhD in Biochemistry from The University of Bonn. Stephanie attended the university from 1997 to 2001.